Program

Medical Students Congress

Opening Ceremony

Prof.dr.sc. Nikolina Bašić Jukić

Welcome Reception

Diabetes & CKD — What’s Next?

Obesity as a Renal–Endocrine Disease

Should SGLT2 inhibitors be started in stage 4 CKD universally?

From Uremia to Immunometabolism: The Hormonal Reset After Kidney Transplant

Dyslipidemia in CKD: Beyond LDL - Understanding the Unique Lipid Phenotype

Therapeutic Strategies in CKD Dyslipidemia: Evidence, Controversies & New Agents

Dyslipidemia in Dialysis & Transplant Patients: Special Populations, Special Strategies

Mitochondrial dysfunction in diabetic kidney disease

Gut microbiome–uremia–insulin resistance axis

Epigenetics of CKD progression

FGF23 as a cardiovascular hormone

Klotho replacement strategies

Novel phosphate binders & non-calcium approaches

Calcimimetics Vs Surgery

Adynamic bone disease in diabetics

Posttransplant bone disease

Integrating SGLT2i, GLP-1RA, and MRAs across CKD stages

ACEi/ARB + SGLT2 inhibitor + Non-Steroidal MRA — For Every Patient with diabetic CKD?

cardiologist - endocrinologist - nephrologist

Resistant hypertension in CKD

Non-steroidal MRAs

Renal denervation in the focus

Endocrine disruptors & kidney disease

Thyroid dysfunction in dialysis and kidney transplantation

Testosterone deficiency in CKD

(In)fertility in female patients with CKD

Dialysate glucose personalization

Protein-energy wasting vs insulin resistance

Metabolomics-guided nutrition in ESRD

Hormonal circadian rhythms in dialysis scheduling

SGLT1/2 dual inhibitors

Anti-inflammatory biologics in DKD

Gene therapy for monogenic diabetes & nephropathy

Growth and development in children with CKD

Hypertrension

TBD

Interpreting complex calcium–phosphate–PTH patterns

Continupus glucose monitoring data interpretation in renal failure

Integrating nutrition prescription with dialysis clearance

Neck ultrasound

Evaluation of nutritional status